Top Markets
#1 Siren Siren +34.00%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.80%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.32%
#4 Cysic Cysic +17.30%
#5 Velvet Velvet +17.16%
#6 Wiki Cat Wiki Cat +17.08%
#7 PulseChain PulseChain +16.92%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.66%
#9 Perle Perle +14.95%
#10 KUB Coin KUB Coin +14.94%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Rangering i aksjer #31279
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Aksjekurs
$0.3799
Markedsverdi
$13.35M
Endring (1 dag)
-8.48%
Endring (1 år)
-88.79%
Land
US
Handel Skye Bioscience, Inc. (SKYE)

Kategori

Healthcare
Utbytteavkastning for Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (aksjesymbol: SKYE) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Skye Bioscience, Inc. (SKYE) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE